After Friday's surge lifted the Dow Jones Industrial Average
Despite all that, the health care sector saw two major buyouts today, and investors are getting set for a potential blockbuster drug approval tomorrow along with second-quarter earnings from an industry stalwart.
Let's take see how the three major indexes are faring and take a closer look at why the health care sector is trouncing the broader market.
|Dow Jones Industrial Average||(21.65)||(0.17%)||12,755.44|
Source: Yahoo! Finance as of 2:30 p.m.
In other deal-making news, GlaxoSmithKline is up slightly despite acquiring Human Genome Sciences
Dow component Johnson & Johnson
Speaking of dividends, the Dow is loaded with companies with solid dividend payouts and highly sustainable business models built for the long haul. The stocks highlighted in The Motley Fool's new special FREE report, "The 3 Dow Stocks Dividend Investors Need," all have an X factor that makes them stand out from their illustrious Dow peers. Download it now, for free.
David Williamson holds no position in any company mentioned. Click here to see his holdings and a short bio. The Motley Fool owns shares of Johnson & Johnson. Motley Fool newsletter services have recommended buying shares of and creating a diagonal call position in Johnson & Johnson. The Motley Fool has a disclosure policy.
We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.
More from The Motley Fool
Does a Strong Start Make 2018 a Sure Winner for Stocks?
Find out whether the so-called "January effect" is real.
Meet the 2018 Dogs of the Dow
Learn the basics of this simple dividend-investing strategy.
The Dow's Worst Day in 2017
Even with big gains, there were some scary times for the average.